Machine signal
Active cluster buy — 4 distinct insiders, $280K, window ends Aug 31, 2026.
Figures computed from official regulatory filings — .
Analysttarget 21.83 USD (+379%) · consensus 4.8/5 · 5 buy · 0 hold · 0 sell
Ownershipinsiders 3.67% · institutions 27.75% · short 6.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Quoin Pharmaceuticals Ltd. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
22 buys1 sell— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| MYERS MICHAELtrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | Cluster |
| SEC |
| Culverwell Anthony Jamestrack record | Buy | $30K | conv 53ClusterFirst in 12mo | SEC |
| Carter Denise P.track record | Buy | $100K | conv 68ClusterFirst in 12mo | SEC |
| Culverwell Anthony Jamestrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Carter Denise P.track record | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| MYERS MICHAELtrack record | Buy | $100K | conv 72ClusterFirst in 12mo | SEC |
| Lawlor Sally Bridget | Buy | $50K | conv 88ClusterFirst in 12mo | SEC |
| Lawlor Sally Bridget | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC |
| Culverwell Anthony Jamestrack record | Award | $161.5K | SEC |
| LANGER DENNIStrack record | Award | $177.9K | SEC |
| LANGER DENNIStrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MYERS MICHAELtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Leong Natalie Ee Mun | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| SEMBER MICHAEL T | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Carter Denise P.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cooper Joseph Patrick | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lawlor Sally Bridget | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Culverwell Anthony Jamestrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lawlor Sally Bridget | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| LANGER DENNIStrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |
| LANGER DENNIStrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |
| LANGER DENNIStrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |
| LANGER DENNIStrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | First in 12mo | SEC |
| LANGER DENNIStrack record | Buy | $128.6K | conv 68First in 12mo | SEC |
| LANGER DENNIStrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |